How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,627 results for

Lice

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1521. Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System

Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Safety (...) and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System (pfm-01/2005) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00390702 Recruitment Status : Completed First Posted : October 20, 2006 Last Update Posted : November 7, 2018 Sponsor: pfm medical ag Collaborator: Aix Scientifics Information provided

2006 Clinical Trials

1522. Procedural Success and Safety of the Nit-Occlud® Patent Foramen Ovale (PFO) Closure Device and Its Application System

Procedural Success and Safety of the Nit-Occlud® Patent Foramen Ovale (PFO) Closure Device and Its Application System Procedural Success and Safety of the Nit-Occlud® Patent Foramen Ovale (PFO) Closure Device and Its Application System - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. Procedural Success and Safety of the Nit-Occlud® Patent Foramen Ovale (PFO) Closure Device and Its Application System (09k003) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00968032 Recruitment Status : Completed First

2009 Clinical Trials

1523. Intestinal Endocellular Symbiotic Bacterium of the Macaque Louse Pedicinus obtusus: Distinct Endosymbiont Origins in Anthropoid Primate Lice and the Old World Monkey Louse Full Text available with Trip Pro

Intestinal Endocellular Symbiotic Bacterium of the Macaque Louse Pedicinus obtusus: Distinct Endosymbiont Origins in Anthropoid Primate Lice and the Old World Monkey Louse A symbiotic bacterium of the macaque louse, Pedicinus obtusus, was characterized. The symbiont constituted a gammaproteobacterial lineage distinct from the symbionts of anthropoid primate lice, localized in the midgut epithelium and the ovaries and exhibiting AT-biased genes and accelerated molecular evolution

2009 Applied and environmental microbiology

1524. Three mutations identified in the voltage-sensitive sodium channel α-subunit gene of permethrin-resistant human head lice reduce the permethrin sensitivity of house fly Vssc1 sodium channels expressed in Xenopus oocytes Full Text available with Trip Pro

Three mutations identified in the voltage-sensitive sodium channel α-subunit gene of permethrin-resistant human head lice reduce the permethrin sensitivity of house fly Vssc1 sodium channels expressed in Xenopus oocytes Point mutations in the para-orthologous sodium channel alpha-subunit of the head louse (M815I, T917I, and L920F) are associated with permethrin resistance and DDT resistance. These mutations were inserted in all combinations using site-directed mutagenesis at the corresponding (...) of permethrin resistance in head lice. Comparison of the expression rates of channels containing single, double and triple mutations with that of Vssc1(WT)/Vsscbeta channels indicates that the M827I mutation may play a role in rescuing the decreased expression of channels containing T929I.

2007 Insect biochemistry and molecular biology

1525. Shaving for head lice is unnecessary and distressing Full Text available with Trip Pro

Shaving for head lice is unnecessary and distressing 16096317 2005 08 24 2018 11 13 1756-1833 331 7513 2005 Aug 13 BMJ (Clinical research ed.) BMJ Shaving for head lice is unnecessary and distressing. 405 Brenton Christine M CM eng Comment Letter England BMJ 8900488 0959-8138 AIM IM BMJ. 2005 Jun 25;330(7506):1510 15976435 Animals Hair Removal psychology Health Promotion methods Humans Lice Infestations prevention & control Pediculus Scalp Dermatoses prevention & control Western Australia 2005

2005 BMJ : British Medical Journal

1526. Combing and combating head lice: Choose between four successive combings or two applications of pediculicide Full Text available with Trip Pro

Combing and combating head lice: Choose between four successive combings or two applications of pediculicide 16096290 2005 08 24 2018 11 13 1756-1833 331 7513 2005 Aug 13 BMJ (Clinical research ed.) BMJ Combing and combating head lice. 362-3 Dawes Martin M eng Comment Editorial England BMJ 8900488 0959-8138 0 Hair Preparations 0 Insecticides AIM IM BMJ. 2005 Aug 13;331(7513):384-7 16085658 Animals Hair Preparations Humans Hygiene Insecticides Lice Infestations prevention & control Pediculus

2005 BMJ : British Medical Journal

1527. Shaving can be safer head lice treatment than insecticides Full Text available with Trip Pro

Shaving can be safer head lice treatment than insecticides 15976435 2005 07 08 2018 11 13 1756-1833 330 7506 2005 Jun 25 BMJ (Clinical research ed.) BMJ Shaving can be safer head lice treatment than insecticides. 1510 Lwegaba Anthony A eng Comment Letter England BMJ 8900488 0959-8138 0 Insecticides AIM IM BMJ. 2005 May 21;330(7501):1194-8 15905257 BMJ. 2005 Aug 13;331(7513):405 16096317 Animals Hair Removal methods Humans Insecticides adverse effects Lice Infestations therapy Pediculus Scalp

2005 BMJ : British Medical Journal

1528. Worldwide Prevalence of Head Lice Full Text available with Trip Pro

Worldwide Prevalence of Head Lice 18760032 2008 12 02 2018 11 13 1080-6059 14 9 2008 Sep Emerging infectious diseases Emerging Infect. Dis. Worldwide prevalence of head lice. 1493-4 10.3201/eid1409.080368 Falagas Matthew E ME Matthaiou Dimitrios K DK Rafailidis Petros I PI Panos George G Pappas Georgios G eng Letter Review United States Emerg Infect Dis 9508155 1080-6040 IM Animals Global Health Humans Lice Infestations epidemiology Pediculus 10 2008 9 2 9 0 2008 12 17 9 0 2008 9 2 9 0 ppublish

2008 Emerging Infectious Diseases

1529. Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice

Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached (...) the maximum number of saved studies (100). Please remove one or more studies before adding more. Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00672971 Recruitment Status : Completed

2008 Clinical Trials

1530. Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice

difficulty such as chest tightness or wheezing. One participants had wheezing as medical history which continued without increase in severity throughout the treatment. Participants Clinically Cured of Head Lice 14 Days After Last Treatment [ Time Frame: Day 7±1 and Day 14 or Day 21 ] No live lice (including adults and nymphs) and nits at Day 7±1 and final lice assessment on either Day 14 (subjects not requiring retreatment) or Day 21 (for retreated subjects). Secondary Outcome Measures : Evaluation (...) Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please

2008 Clinical Trials

1531. Dose Ranging Study of Ivermectin Treatment Conditioner in Subjects With Head Lice Infestation

: March 30, 2012 Sponsor: Topaz Pharmaceuticals Inc Information provided by (Responsible Party): Topaz Pharmaceuticals Inc Study Details Study Description Go to Brief Summary: This is a Phase 2 single center study designed to compare the safety, local tolerability, and efficacy of 3 strengths of ivermectin treatment conditioner to placebo. Condition or disease Intervention/treatment Phase Pediculus Humanus Capitis (Head Lice) Drug: ivermectin treatment conditioner Drug: Placebo, vehicle control Phase (...) information Responsible Party: Topaz Pharmaceuticals Inc ClinicalTrials.gov Identifier: Other Study ID Numbers: TOP003 First Posted: March 9, 2009 Results First Posted: March 30, 2012 Last Update Posted: March 30, 2012 Last Verified: March 2012 Keywords provided by Topaz Pharmaceuticals Inc: head lice Pediculus humanus capitis ivermectin Additional relevant MeSH terms: Layout table for MeSH terms Lice Infestations Parasitic Diseases Ectoparasitic Infestations Skin Diseases, Parasitic Skin Diseases

2009 Clinical Trials

1532. Ivermectin in the Treatment of Head Lice

: August 22, 2011 Last Verified: August 2011 Keywords provided by Johnson & Johnson Consumer and Personal Products Worldwide: pediculosis capitis pediculus Additional relevant MeSH terms: Layout table for MeSH terms Parasitic Diseases Lice Infestations Ectoparasitic Infestations Skin Diseases, Parasitic Skin Diseases, Infectious Skin Diseases Ivermectin Malathion Antiparasitic Agents Anti-Infective Agents Cholinesterase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action (...) of age. In recent years an increasing prevalence of lice infestation in schools, day care centres, and summer day camps is believed to be partly due to increasing lice resistance to currently available standard treatments for pediculosis (infestation with lice). There is a need for new effective backup treatments for this common condition of head lice infestation. This is a double-blind, randomized, parallel-group, study in several clinical centres comparing ivermectin as tablets to malathion 0.5

2009 Clinical Trials

1533. Control of Head Lice Infestations in Children and Adults

Summary: The goal of this study is to see if heated air will kill head lice and their eggs. The treatment visit is approximately 1 hour long with a follow up phone call. Condition or disease Intervention/treatment Phase Pediculosis Device: lousebuster Not Applicable Detailed Description: Head lice strikes fear into the hearts of parents of school age children. Ridding a child of head lice is one of the most frustrating experiences a parent can face. The objective of this project is to test whether (...) louse desiccation using our prototype is an effective means of controlling head louse infestations in children. Children age 6 and over are included in this study. Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 543 participants Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: Control of Head Lice in Children and Adults Study Start Date : June 2007 Actual Primary

2008 Clinical Trials

1534. Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice

Posted: February 13, 2006 Last Update Posted: December 23, 2013 Last Verified: November 2013 Keywords provided by Taro Pharmaceuticals USA: Pediculosis Head Lice Additional relevant MeSH terms: Layout table for MeSH terms Parasitic Diseases Lice Infestations Ectoparasitic Infestations Skin Diseases, Parasitic Skin Diseases, Infectious Skin Diseases Malathion Cholinesterase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Cholinergic Agents Neurotransmitter Agents (...) Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2006 Clinical Trials

1535. Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice

0.05%Formulation, for the Control of Head Lice in Pediatric and Adult Subjects With Pediculosis Capitis Study Start Date : December 2005 Actual Primary Completion Date : October 2006 Actual Study Completion Date : December 2006 Resource links provided by the National Library of Medicine available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: 1 MALG Drug: MALG 30 minute application Active Comparator: 2 Ovide Drug: Ovide (malathion) lotion 0.05% 8-12 hour application (...) Taro Pharmaceuticals USA More Information Go to Layout table for additonal information Responsible Party: Medical Director, Taro Pharmaceuticals USA ClinicalTrials.gov Identifier: Other Study ID Numbers: MALG-0506 First Posted: October 26, 2005 Last Update Posted: December 23, 2013 Last Verified: November 2013 Keywords provided by Taro Pharmaceuticals USA: Head Lice Pediculosis capitis Additional relevant MeSH terms: Layout table for MeSH terms Parasitic Diseases Lice Infestations Ectoparasitic

2005 Clinical Trials

1536. Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice

by Insight Pharmaceuticals. Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 403 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single (Outcomes Assessor) Primary Purpose: Treatment Official Title: A Multi-Center Phase III Study to Evaluate Malathion Gel 0.5% Formulation, for the Control of Head Lice in Pediatric Subjects and Adult Subjects With Pediculosis Capitis Study Start Date : August 2009 (...) Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2009 Clinical Trials

1537. Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice

Pharmaceuticals. Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 254 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single (Outcomes Assessor) Primary Purpose: Treatment Official Title: A Multi-Center Phase III Study to Evaluate Ovide Lotion 0.5% Formulation, for the Control of Head Lice in Pediatric Subjects and Adult Subjects With Pediculosis Capitis Study Start Date : August 2009 Actual Primary (...) Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2009 Clinical Trials

1538. Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice

Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00927407 Recruitment Status : Completed First Posted : June 25, 2009 Last Update Posted : December 24, 2013

2009 Clinical Trials

1539. A randomized, investigator-blinded, time-ranging study of the comparative efficacy of 0.5% malathion gel versus Ovide Lotion (0.5% malathion) or Nix Crème Rinse (1% permethrin) used as labeled, for the treatment of head lice. (Abstract)

A randomized, investigator-blinded, time-ranging study of the comparative efficacy of 0.5% malathion gel versus Ovide Lotion (0.5% malathion) or Nix Crème Rinse (1% permethrin) used as labeled, for the treatment of head lice. One hundred seventy-two subjects with head lice participated in a five-way, investigator-blinded, parallel-group, active-controlled study comparing 0.5% malathion gel (30, 60, and 90 minutes applications), Ovide Lotion (0.5% malathion), and Nix Crème Rinse (1% permethrin (...) ). All subjects were treated on day 1. Participants were reevaluated at day 8 +/- 1 and those with live lice were retreated with the same product, for the same duration as day 1. Cure, defined as the absence of live lice, was evaluated 14 +/- 2 days after the last treatment and 161 subjects completed the study according to the protocol. Compared to Nix, treatment success rates were statistically superior for all malathion gel and Ovide groups. Retreatment rate for Nix was 70%, which was statistically

2007 Pediatric dermatology Controlled trial quality: uncertain

1540. Treatment of head lice with dimeticone 4% lotion: comparison of two formulations in a randomised controlled trial in rural Turkey. Full Text available with Trip Pro

Treatment of head lice with dimeticone 4% lotion: comparison of two formulations in a randomised controlled trial in rural Turkey. Dimeticone 4% lotion was shown to be an effective treatment for head louse infestation in two randomised controlled trials in England. It is not affected by insecticide resistance but efficacy obtained (70-75%) was lower than expected. This study was designed to evaluate efficacy of dimeticone 4% lotion in a geographically, socially, and culturally different setting (...) , in rural Turkey and, in order to achieve blinding, it was compared with a potential alternative formulation.Children from two village schools were screened for head lice by detection combing. All infested students and family members could participate, giving access to treatment for the whole community. Two investigator applied treatments were given 7 days apart. Outcome was assessed by detection combing three times between treatments and twice the week following second treatment.In the intention

2009 BMC public health Controlled trial quality: uncertain

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>